Skip to content

Rehab After Hip Fracture With Wearable Device

Assessing the Outcome of Rehabilitation After Hip Fracture With a Wearable Device

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04906265
Enrollment
80
Registered
2021-05-28
Start date
2021-05-01
Completion date
2025-12-31
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Hip

Keywords

Fracture of hip, Postural sway, Balance, Rehabilitation, Wearable device

Brief summary

A randomized control trial, including two intervention arms with different methods for rehabilitation after hip fracture, conducted among persons with the need of rehabilitation in their own home.

Detailed description

The increase of the aging population challenges health care providers. Fragility, oste-oporosis, and impaired balance are some major risk factors for hip fracture, an injury causing morbidity, mortality, and loss of independent life. This study aims to study if adding continuous measures of body positions and movements 24 hours a day with an Inertial Measurement Unit (IMU) can, compared to standard rehabilitation alone, optimize rehabilitation after hip fracture. The study is designed as a randomized controlled trial. Patients with hip fracture that require rehabilitation at home, will be invited to participate in the study. Those who accept to participate will randomly be assigned to intervention- or control group. The intervention comprises standard rehabilitation and continuous measures of body positions and movements 24 hours a day with an IMU. Standard rehabilitation comprises of home-visits by a PT, where an individualized rehabilitation plan is outlined together with the patient. The plan includes individually tailored functional exercises. The plan also includes individually tailored walking exercises, indoor and outdoor when possible. At each home visit, the PT provides feedback to the participant based on the data from the IMU, i.e. body positions (time spent in sitting, standing, lying down) and body movements (steps per day, step length, walking speed, sideway deviation during walking). The control group receives standard rehabilitation only. The primary outcome is balance, in terms of postural sway measured with the IMU, and functional balance measured with the Functional Balance test for Geriatric patients, secondary outcomes are health-related quality of life, measured with the EQ5D, functional independence in everyday activities, measured with the Barthel Index, fear of falling, measured with the Falls Efficacy Scale International, satisfaction with rehabilitation, measured with a single question, and compliance to the intervention .

Interventions

OTHERIntervention

The intervention comprises of standard rehabilitation and continuous measures of body positions and movements 24 hour a day with an IMU. Standard rehabilitation comprises of home-visits by a PT, where an individualized rehabilitation plan is outlined together with the patient. The plan includes individually tailored functional exercises. The plan also includes individually tailored walking exercises, indoor and outdoor when possible. At each home visit, the PT provides feedback to the participant based on the data from the IMU, i.e. body positions (time spent in sitting, standing, lying down) and body movements (steps per day, step length, walking speed, sideway deviation during walking)

OTHERControl

Standard rehabiliation

Sponsors

Malmo Municipality, Sweden
CollaboratorUNKNOWN
Lund University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

Randomized controlled clinical trial

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with a hip fracture, living in Malmö, and who are unable to visit a rehabilitation facility and therefore request treatment at home. Another inclusion criterion is the ability to read and understand the Swedish language or the ability to understand information through an interpreter.

Exclusion criteria

* the presence of major neurological diseases that have an impact on balance and walk-ing ability; a diagnosed cognitive disease, or moderate to severe cognitive impairment as assessed by a physiotherapist

Design outcomes

Primary

MeasureTime frameDescription
Change in postural swayBaseline, through study completion, on average 3 monthsMedio-lateral and anterior-posterior sway measured with the IMU in mm/sec

Secondary

MeasureTime frameDescription
Change in functionBaseline and after study completion, on average 3 monthsEQ5D5L index from 0 (dead) to 1 (best imaginable health)
Change in health-related quality of lifeBaseline and after study completion, on average 3 monthsEQ5D visual analogue scale, graded from 0 (worst health) to 100 (best health)
Change in functional balanceBaseline and after study completion, on average 3 monthsthe Functional Balance test for Geriatric patients, including 4 tasks graded between 0-6,
Change in functional independence i everyday activitiesBaseline and after study completion, on average 3 monthsThe Barthel Index, likert scale, 6 items graded 0, 5, 10, 2 items graded 0, 5 and 2 items graded 0, 5, 10, 15. 100 highest possible score (best)
Satisfaction with rehabilitationAfter study completion, on average 3 monthsMeasured with a single question if the person thinks their need of rehabilitation is provided for, with four possible answers
Compliance to the interventionThrough study completion, on average 3 monthsMeasured with a single question on how much the participant has trained since the last home visit, with three possible answers
Change in fear of fallingBaseline and after study completion, on average 3 monthsthe Falls Efficacy Scale International , (22), comprising 16 questions with four possible answers

Countries

Sweden

Contacts

Primary ContactEva Ekvall Hansson, Professor
eva.ekvall-hansson@med.lu.se+46462221986
Backup ContactAgneta Malmgren Fänge, A professor
agneta.malmgren_fange@med.lu.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026